News

Prof. Hening Lin brings expertise in enzymes to UChicago, bridging scientists, engineers and doctors to translate research to ...
"Synthetic biology tools like optogenetics allow us to precisely tune complex cellular processes, something traditional drug screening cannot do," said Maxwell Wilson, Ph.D., Co-Founder and Chief ...
A novel optogenetic screening platform enables a high-throughput screen and identified several integrated stress response-potentiating compounds.
Molecular glues, tiny molecules that connect one protein to another, are promising targets for pharmaceutical research. By ...
A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.
A key patent for Merck’s blockbuster drug Keytruda will expire in 2028. The cancer therapy brought the company $29.5 billion last year. Keytruda may also face “ price setting ” from the Inflation ...